Meeting
2021 ASCO Annual Meeting
Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers.
Authors
Alberto Hernando-Calvo
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
Alberto Hernando-Calvo , Alejandra Rezqallah , Eoghan Ruadh Malone , Omar Saavedra Santa Gadea , Anna Spreafico , Maria Vieito , Ilan Weinreb , Susana Aguilar , Anneli Eliason , Juan David Assaf , Angela Rodriguez , Coro Bescos , Katherine Lajkosz , Juan Lorente , Sarah Jennings , Enriqueta Felip , Elena Garralda , Lillian L. Siu , Aaron Richard Hansen , Irene Brana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Other Head and Neck Cancer (Salivary, Thyroid)
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6081)
DOI
10.1200/JCO.2021.39.15_suppl.6081
Abstract #
6081
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
NCI-MATCH (Molecular Analysis for Therapy Choice) – a national signal finding trial.
First Author: Barbara A. Conley
Poster
2013 ASCO Annual Meeting
Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies) trial.
First Author: Giuseppe Giaccone
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline mutational profile in metastatic urothelial malignancy.
First Author: Emily Barry
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco